Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 304, pseudogene (RN7SL304P)

Target
RN7SL304P
Molecular classification
Pseudogene, Noncoding RNA pseudogene, 7SL RNA pseudogene
01

Overview

RNA, 7SL, cytoplasmic 304, pseudogene (RN7SL304P) is a human genomic locus classified as a pseudogene[4][7]. It is part of a large family derived from the 7SL RNA gene, which provides the RNA core for the signal recognition particle (SRP) complex essential for directing nascent proteins to the endoplasmic reticulum[1][2]. Unlike functional 7SL RNA genes, pseudogenes like RN7SL304P are generally considered to be nonfunctional, containing inactivating mutations or truncations that prevent their expression or canonical role in SRP assembly. Most 7SL-derived pseudogenes, including RN7SL304P, do not code for functional proteins or participate in established regulatory functions, and there is no evidence to support a role as a therapeutic target or biomarker[2][4][7]. However, emerging research highlights that some pseudogenes may have noncoding RNA-based regulatory activities or structural genome functions, but for RN7SL304P specifically, such roles have not been experimentally demonstrated[6].

Other names
RN7SL304P
02

Biological functions

Unknown (no evidence of a protein-coding or canonical regulatory role for this specific pseudogene)[4][7]Possible noncoding RNA-based regulation (inference from pseudogene biology)[6]
03

Disease associations

Other (no direct disease association is defined for RN7SL304P specifically; general note: other 7SL RNA family transcripts or pseudogenes have been implicated in regulatory phenomena in cancer and stress, but not for this individual pseudogene)[5][6]

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 304, pseudogene (RN7SL304P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 304, pseudogene (RN7SL304P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call